Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. decreased its position in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 7.7% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 68,933 shares of the company’s stock after selling 5,759 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Nature’s Sunshine Products were worth $939,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Paradigm Capital Management Inc. NY boosted its position in shares of Nature’s Sunshine Products by 26.8% during the 2nd quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock valued at $10,475,000 after purchasing an additional 146,879 shares in the last quarter. Panagora Asset Management Inc. grew its position in Nature’s Sunshine Products by 8.3% in the second quarter. Panagora Asset Management Inc. now owns 70,338 shares of the company’s stock worth $1,060,000 after buying an additional 5,392 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Nature’s Sunshine Products by 12.6% in the second quarter. Bank of New York Mellon Corp now owns 48,589 shares of the company’s stock valued at $732,000 after buying an additional 5,425 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Nature’s Sunshine Products by 25.7% during the 2nd quarter. American Century Companies Inc. now owns 260,479 shares of the company’s stock worth $3,925,000 after acquiring an additional 53,221 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Nature’s Sunshine Products in the 2nd quarter worth $180,000. Institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Price Performance

NASDAQ:NATR opened at $15.65 on Wednesday. The stock’s 50-day moving average is $14.73 and its two-hundred day moving average is $14.55. The stock has a market cap of $289.15 million, a PE ratio of 17.78 and a beta of 0.93. Nature’s Sunshine Products, Inc. has a fifty-two week low of $10.81 and a fifty-two week high of $21.72.

Insider Activity

In other news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the business’s stock in a transaction on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total value of $40,170.00. Following the completion of the sale, the insider now directly owns 69,347 shares in the company, valued at approximately $928,556.33. The trade was a 4.15 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 7,499 shares of company stock worth $99,802 in the last ninety days. Corporate insiders own 4.70% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 10th. Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target for the company. Finally, Canaccord Genuity Group assumed coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 price objective on the stock.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.